TY - JOUR
T1 - Multi-Target Mechanisms of Phytochemicals in Alzheimer’s Disease
T2 - Effects on Oxidative Stress, Neuroinflammation and Protein Aggregation
AU - Sharifi-Rad, Javad
AU - Rapposelli, Simona
AU - Sestito, Simona
AU - Herrera-Bravo, Jesús
AU - Arancibia-Diaz, Alejandra
AU - Salazar, Luis A.
AU - Yeskaliyeva, Balakyz
AU - Beyatli, Ahmet
AU - Leyva-Gómez, Gerardo
AU - González-Contreras, Carlos
AU - Gürer, Eda Sönmez
AU - Martorell, Miquel
AU - Calina, Daniela
N1 - Publisher Copyright:
© 2022 by the authors.
PY - 2022/9
Y1 - 2022/9
N2 - Alzheimer’s disease (AD) is a neurodegenerative disease characterized by a tangle-shaped accumulation of beta-amyloid peptide fragments and Tau protein in brain neurons. The pathophysiological mechanism involves the presence of Aβ-amyloid peptide, Tau protein, oxidative stress, and an exacerbated neuro-inflammatory response. This review aims to offer an updated compendium of the most recent and promising advances in AD treatment through the administration of phytochemicals. The literature survey was carried out by electronic search in the following specialized databases PubMed/Medline, Embase, TRIP database, Google Scholar, Wiley, and Web of Science regarding published works that included molecular mechanisms and signaling pathways targeted by phytochemicals in various experimental models of Alzheimer’s disease in vitro and in vivo. The results of the studies showed that the use of phytochemicals against AD has gained relevance due to their antioxidant, anti-neuroinflammatory, anti-amyloid, and anti-hyperphosphorylation properties of Tau protein. Some bioactive compounds from plants have been shown to have the ability to prevent and stop the progression of Alzheimer’s.
AB - Alzheimer’s disease (AD) is a neurodegenerative disease characterized by a tangle-shaped accumulation of beta-amyloid peptide fragments and Tau protein in brain neurons. The pathophysiological mechanism involves the presence of Aβ-amyloid peptide, Tau protein, oxidative stress, and an exacerbated neuro-inflammatory response. This review aims to offer an updated compendium of the most recent and promising advances in AD treatment through the administration of phytochemicals. The literature survey was carried out by electronic search in the following specialized databases PubMed/Medline, Embase, TRIP database, Google Scholar, Wiley, and Web of Science regarding published works that included molecular mechanisms and signaling pathways targeted by phytochemicals in various experimental models of Alzheimer’s disease in vitro and in vivo. The results of the studies showed that the use of phytochemicals against AD has gained relevance due to their antioxidant, anti-neuroinflammatory, anti-amyloid, and anti-hyperphosphorylation properties of Tau protein. Some bioactive compounds from plants have been shown to have the ability to prevent and stop the progression of Alzheimer’s.
KW - Alzheimer’s disease
KW - molecular mechanisms
KW - neuroinflammation
KW - neuroprotective effects
KW - oxidative damage
KW - phytochemicals
KW - protein aggregation
UR - https://www.scopus.com/pages/publications/85138596726
U2 - 10.3390/jpm12091515
DO - 10.3390/jpm12091515
M3 - Artículo de revisión
AN - SCOPUS:85138596726
SN - 2075-4426
VL - 12
JO - Journal of Personalized Medicine
JF - Journal of Personalized Medicine
IS - 9
M1 - 1515
ER -